Stay updated on KSI-301 vs Aflibercept in Wet AMD Clinical Trial
Sign up to get notified when there's something new on the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page.

Latest updates to the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 was removed. This is a minor maintenance update that does not change study information.SummaryDifference0.0%

- Check65 days agoChange DetectedNew revision tag v3.4.2 appears and the site-wide funding notice was removed; no trial data or user actions were affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check72 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH operations. Updated the site version from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check80 days agoChange DetectedAdded a glossary toggle and updated metadata labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'), while removing earlier labels ('Last Update Submitted that met QC Criteria', 'No FEAR Act data', 'Revision: v3.3.4').SummaryDifference0.1%

Stay in the know with updates to KSI-301 vs Aflibercept in Wet AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KSI-301 vs Aflibercept in Wet AMD Clinical Trial page.